Lymphomatoid granulomatosis induced by imatinib-treatment.
Yazdi
Amir S
AS
Metzler
Gisela
G
Weyrauch
Susanne
S
Berneburg
Mark
M
Bitzer
Michael
M
Müller-Hermelink
Hans-Konrad
HK
Röcken
Martin
M
D000369:Aged, 80 and over; D000970:Antineoplastic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001549:Benzamides; D005260:Female; D006801:Humans; D000068877:Imatinib Mesylate; D008113:Liver Neoplasms / Q000188:drug therapy / Q000556:secondary; D008171:Lung Diseases / Q000139:chemically induced / Q000473:pathology; D008230:Lymphomatoid Granulomatosis / Q000139:chemically induced* / Q000473:pathology; D010879:Piperazines / Q000009:adverse effects* / Q000627:therapeutic use; D011743:Pyrimidines / Q000009:adverse effects* / Q000627:therapeutic use; D012871:Skin Diseases / Q000139:chemically induced* / Q000473:pathology
D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate